Tjoapack successfully launches its first Pre-Filled Syringe (PFS) project, expanding its packaging capabilities with advanced automation and safety features to meet growing market demand.
Our CEO Dexter Tjoa is talking about the recent expansion of our facility in the Netherlands and the benefits of doubling our packaging capacity. In Packaging Gateway’s article, he also discusses the agility within the packaging supply chain...
Our new parenteral packaging line has arrived at Tjoapack Netherlands. At Tjoapack, we now provide expert packaging solutions for Pre-filled Syringes, including assembly, labelling, blistering and cartoning.
PMPS sat down with industry experts from Cognizant, Celegence, and Tjoapack to discover how digital advances are improving the life sciences sector, from manufcturing all the way to the patient.
Global pharmaceutical contract packaging organisation (CPO), Tjoapack has invested in a new high-speed packaging line for pre-filled syringes and vials at its production facilities in both Europe and the US.
Our VP Business Development & Marketing Marcelo Cruz sat down with European Pharmaceutical Manufacturer to discuss the 2023 trends in drug development and pharma packaging.
We are pleased to announce that our US facility in Clinton, TN has successfully undergone an initial FDA Inspection by the Medical Device group, conducted on January 17-19.
This February Tjoapack was happy to attend Pharmapack Europe 2023 – a perfect platform for establishing and developing business relations between drug delivery and pharma packaging companies.
The national drug code (NDC) is a unique number used by the US Food and Drug Administration (FDA) to identify and report drugs. The FDA is mandating new standardised NDC regulations for drugs sold in the US. Traditionally, a 10-digit code...
Ready to shape the future of your pharmaceutical supply chain?